BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11815455)

  • 1. Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action.
    Renström E; Barg S; Thévenod F; Rorsman P
    Diabetes; 2002 Feb; 51 Suppl 1():S33-6. PubMed ID: 11815455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming of insulin granules for exocytosis by granular Cl(-) uptake and acidification.
    Barg S; Huang P; Eliasson L; Nelson DJ; Obermüller S; Rorsman P; Thévenod F; Renström E
    J Cell Sci; 2001 Jun; 114(Pt 11):2145-54. PubMed ID: 11493650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
    Tian YA; Johnson G; Ashcroft SJ
    Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
    Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of sulfonylurea- and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein ClC-3.
    Li DQ; Jing X; Salehi A; Collins SC; Hoppa MB; Rosengren AH; Zhang E; Lundquist I; Olofsson CS; Mörgelin M; Eliasson L; Rorsman P; Renström E
    Cell Metab; 2009 Oct; 10(4):309-15. PubMed ID: 19808023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea receptors, ion channels, and fruit flies.
    Boyd AE
    Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of exocytosis in insulin-secreting B-cells and glucagon-secreting A-cells.
    Barg S
    Pharmacol Toxicol; 2003 Jan; 92(1):3-13. PubMed ID: 12710591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
    Eliasson L; Renström E; Ammälä C; Berggren PO; Bertorello AM; Bokvist K; Chibalin A; Deeney JT; Flatt PR; Gäbel J; Gromada J; Larsson O; Lindström P; Rhodes CJ; Rorsman P
    Science; 1996 Feb; 271(5250):813-5. PubMed ID: 8628999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structure and action mechanism of sulfonylurea].
    Tasaka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():333-8. PubMed ID: 12387014
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolbutamide stimulates exocytosis of glucagon by inhibition of a mitochondrial-like ATP-sensitive K+ (KATP) conductance in rat pancreatic A-cells.
    Høy M; Olsen HL; Bokvist K; Buschard K; Barg S; Rorsman P; Gromada J
    J Physiol; 2000 Aug; 527 Pt 1(Pt 1):109-20. PubMed ID: 10944174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways.
    Straub SG; Cosgrove KE; Ammälä C; Shepherd RM; O'Brien RE; Barnes PD; Kuchinski N; Chapman JC; Schaeppi M; Glaser B; Lindley KJ; Sharp GW; Aynsley-Green A; Dunne MJ
    Diabetes; 2001 Feb; 50(2):329-39. PubMed ID: 11272144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic and extrapancreatic sulfonylurea receptors.
    Panten U; Schwanstecher M; Schwanstecher C
    Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-stimulated signaling pathways in biphasic insulin secretion.
    Straub SG; Sharp GW
    Diabetes Metab Res Rev; 2002; 18(6):451-63. PubMed ID: 12469359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of action of glyburide on the beta cell.
    Boyd AE; Aguilar-Bryan L; Nelson DA
    Am J Med; 1990 Aug; 89(2A):3S-10S; discussion 51S-53S. PubMed ID: 2117388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas.
    Henquin JC
    Biochimie; 2017 Dec; 143():3-9. PubMed ID: 28711685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon.
    Komatsu M; Sato Y; Yamada S; Yamauchi K; Hashizume K; Aizawa T
    Diabetes; 2002 Feb; 51 Suppl 1():S29-32. PubMed ID: 11815454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ATP-sensitive potassium channels and substances affecting them].
    Pospísilová Y
    Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
    Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
    Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The imidazoline NNC77-0020 affects glucose-dependent insulin, glucagon and somatostatin secretion in mouse pancreatic islets.
    Høy M; Olsen HL; Bokvist K; Petersen JS; Gromada J
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):284-93. PubMed ID: 13680090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.